SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001213900-24-037258
Filing Date
2024-04-29
Accepted
2024-04-29 17:00:17
Documents
17
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 10-K ea0204829-10ka1_therapeu.htm   iXBRL 10-K/A 378947
2 CERTIFICATION ea020482901ex31-1_therapeu.htm EX-31.1 3584
3 CERTIFICATION ea020482901ex31-2_therapeu.htm EX-31.2 3583
4 GRAPHIC image_001.jpg GRAPHIC 7981
  Complete submission text file 0001213900-24-037258.txt   680522

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE txmd-20231231.xsd EX-101.SCH 3246
6 XBRL DEFINITION FILE txmd-20231231_def.xml EX-101.DEF 16947
7 XBRL LABEL FILE txmd-20231231_lab.xml EX-101.LAB 34886
8 XBRL PRESENTATION FILE txmd-20231231_pre.xml EX-101.PRE 18006
20 EXTRACTED XBRL INSTANCE DOCUMENT ea0204829-10ka1_therapeu_htm.xml XML 7564
Mailing Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431
Business Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431 561-961-1900
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

IRS No.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-00100 | Film No.: 24892272
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)